GILD Jan 2025 35.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:12PM EDT. Market open.
Loading interactive chart…
- Investor's Business Daily
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
Gilead stock reversed lower Monday after confirming it's testing a popular weight-loss mechanism as a treatment for a liver disease.
- Investor's Business Daily
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.
- Barrons.com
Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.
Gilead Sciences stock was climbing Friday on hopes that it would get into the obesity-drug game. GLP-1s, the technical name for the popular obesity drugs, has been one of the biggest drivers of pharmaceutical stocks in recent months. Which may be why Gilead stock has gained 2.8% to $64.55 in afternoon trading Friday after Jefferies released a note late Thursday night.
© 2024 Yahoo. All rights reserved.